Why the study?
Are antidepressants safe and effective for the treatment of poststroke depression?
Are antidepressants safe and effective for the treatment of poststroke depression?
SSRIs are considered safe and effective first-line treatments for poststroke depression, provided that individual clinical profiles and potential cardiovascular or cerebrovascular effects are taken into account.
May support SSRIs for poststroke depression with CV monitoring; leaves open need for RCTs on cerebrovascular safety.
Depression is an important complication of stroke. Although antidepressants are widely used for the treatment of poststroke depression (PSD), prescription is critically influenced by their safety, tolerability and by the impact on co-morbidities. The authors reviewed the literature on the use of antidepressants after stroke. Selective serotonin re-uptake inhibitors are effective and have a good profile of safety and tolerability in PSD. They are, therefore, used as first-line drugs in the treatment of PSD, although potential cardiovascular and cerebrovascular effects, drug-drug interactions and intolerability in a minority of patients have to be considered. Other antidepressants appear to be safe and effective in selected patients. PSD patients should be classified according to their clinical profile for the selection of the drug of choice in particular sub-groups of patients.
No takes yet. Share an insight, caveat, or question.
Rampello et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: